Lista de obras - Petrus Järvinen - Dominio Público Uruguay

Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei.

artículo científico publicado en 2017

Clinical Presentation of Pseudomyxoma Peritonei ⬇️

artículo científico publicado el 1 de enero de 2010

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells

scientific article published on 04 November 2018

Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study).

artículo científico publicado en 2017

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis

scientific article published on 24 June 2019

Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin

artículo científico publicado en 2013

From overdiagnosis to overtreatment of small renal mas- can the chain be broken?

artículo científico publicado en 2016

Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei

artículo científico publicado en 2017

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy

artículo científico publicado en 2016

Patient Experience of Systematic Versus Fusion Prostate Biopsies

scientific article published on 15 May 2018

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy

artículo científico publicado en 2020

Randomized Trials Show a Consistent Benefit of Radical Prostatectomy on Mortality Outcomes

scientific article published on 03 July 2019

Repeat multiparametric MRI in prostate cancer patients on active surveillance

artículo científico publicado en 2017

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma

artículo científico publicado en 2020

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

artículo científico publicado en 2022

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium

artículo científico publicado en 2020

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

artículo científico publicado en 2020

Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA -2 study)

artículo científico publicado en 2018

Lista de obras de Petrus Järvinen

Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei.

Clinical Presentation of Pseudomyxoma Peritonei ⬇️

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells

Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study).

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis

Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin

From overdiagnosis to overtreatment of small renal mas- can the chain be broken?

Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei

Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy

Patient Experience of Systematic Versus Fusion Prostate Biopsies

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy

Randomized Trials Show a Consistent Benefit of Radical Prostatectomy on Mortality Outcomes

Repeat multiparametric MRI in prostate cancer patients on active surveillance

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA -2 study)